Medicare Enrolled

Dr. Gina Matacia, MD

Hematology · Cincinnati, OH
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
5520 CHEVIOT RD, Cincinnati, OH 45247
5134514033
In practice since 2007 (19 years)
NPI: 1891906459 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Matacia from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Matacia? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Matacia

Dr. Gina Matacia is a hematology specialist in Cincinnati, OH, with 19 years of NPI registration. Based on federal Medicare data, Dr. Matacia performed 594 Medicare services across 408 unique beneficiaries.

Between the years covered by Open Payments, Dr. Matacia received a total of $4,373 from 29 pharmaceutical and/or device companies across 62 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Matacia is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 12% volume in OH $4,373 industry payments

Medicare Practice Summary

Medicare Utilization ↗
594
Medicare services
Top 12% in OH for hematology
408
Unique beneficiaries
$89
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~31 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
260 $104 $318
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
170 $62 $235
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
41 $44 $158
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
31 $89 $361
New patient office visit, complex (60-74 min) 30 $131 $454
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
27 $129 $451
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
23 $100 $305
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
12 $61 $161
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,373
Total received (2018-2024)
Avg $625/year across 7 years
Bottom 31% in OH for hematology
29
Companies
62
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,087 (70.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,285 (29.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$211
2023
$3,318
2022
$384
2021
$261
2020
$74
2019
$54
2018
$70

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$52
GlaxoSmithKline, LLC.
$37
ABBVIE INC.
$34
Rigel Pharmaceuticals, Inc.
$27
Aveo Pharmaceuticals, Inc.
$22
Alexion Pharmaceuticals, Inc.
$20
AstraZeneca Pharmaceuticals LP
$19
Top 3 companies account for 58.2% of 2024 payments
All-time payments by company (2018-2024) ›
Merck Sharp & Dohme LLC
$3,124
Merck Sharp & Dohme Corporation
$153
Incyte Corporation
$121
Lilly USA, LLC
$116
PFIZER INC.
$85
Janssen Biotech, Inc.
$70
AstraZeneca Pharmaceuticals LP
$65
Amgen Inc.
$65
Novartis Pharmaceuticals Corporation
$62
Celgene Corporation
$60
GlaxoSmithKline, LLC.
$57
Daiichi Sankyo Inc.
$42
Regeneron Healthcare Solutions, Inc.
$36
ABBVIE INC.
$34
Rigel Pharmaceuticals, Inc.
$27
Cumberland Pharmaceuticals, Inc.
$25
Aveo Pharmaceuticals, Inc.
$22
EISAI INC.
$21
Alexion Pharmaceuticals, Inc.
$20
Takeda Pharmaceuticals U.S.A., Inc.
$20
Bayer HealthCare Pharmaceuticals Inc.
$20
Stemline Therapeutics Inc.
$18
EMD Serono, Inc.
$17
TAIHO ONCOLOGY, INC.
$17
Novo Nordisk Inc
$17
Puma Biotechnology, Inc.
$16
Deciphera Pharmaceuticals Inc.
$15
Astellas Pharma US Inc
$15
E.R. Squibb & Sons, L.L.C.
$14
Top 3 companies account for 77.7% of all-time payments
Associated products mentioned in payments ›
BLENREP · CYRAMZA · ELIQUIS · ENHERTU · Enhertu · FOTIVDA · IBRANCE · IMBRUVICA · INLYTA · KEYTRUDA · KISQALI · LIBTAYO · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · MONJUVI · MVASI · NINLARO · Novoeight · OJJAARA · OPDIVO · OXBRYTA · Orserdu · PADCEV · PIQRAY · Pomalyst · QINLOCK · REBLOZYL · Rezlidhia · SANCUSO · Stivarga · TEPMETKO · ULTOMIRIS · VERZENIO · Vectibix · XTANDI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (71%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology and does not inherently indicate bias, but patients may wish to be aware.

Looking for a hematology specialist in Cincinnati?
Compare hematologists in the Cincinnati area by procedure volume, costs, and industry payment transparency.
Browse hematologists nearby

Geographic Context

Hematologists within 10 mi
6
Per 100K population
0.7
County median income
$70,816
Nearest hospital
GLENWOOD BEHAVIORAL HEALTH HOSPITAL
4.4 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Matacia is a clinical cardiology specialist, with above-average Medicare volume (top 12% in OH), with speaking/promotional industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Matacia experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Matacia performed 260 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Matacia receive payments from pharmaceutical companies?
Yes. Dr. Matacia received a total of $4,373 from 29 companies across 62 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Matacia's costs compare to other hematologists in Cincinnati?
Dr. Matacia's average Medicare payment per service is $89. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Matacia) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →